Related Experiment Video
Updated: May 21, 2025
08:17
A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
Published on: February 27, 2018
16.3K
4-Aminopyridine Promotes BMP2 Expression and Accelerates Tibial Fracture Healing in Mice
Govindaraj Ellur1, Prem Kumar Govindappa1, Sandeep Subrahmanian2
1Department of Orthopaedics and Sports Medicine, University of Arizona College of Medicine, Tucson, Arizona.
The Journal of Bone and Joint Surgery. American Volume
|March 22, 2025
Summary
4-aminopyridine (4-AP) significantly enhances bone fracture healing in mice by improving cell function and increasing bone mineral density. This FDA-approved drug shows promise for accelerating recovery and improving biomechanical properties after tibial fractures.
Area of Science:
- Orthopaedic Surgery
- Regenerative Medicine
- Pharmacology
Background:
- Delayed bone healing presents a significant challenge in orthopaedic clinical care.
- The U.S. Food and Drug Administration (FDA)-approved drug 4-aminopyridine (4-AP) has shown efficacy in neurological disorders and multi-tissue injuries.
- Investigating 4-AP's potential to enhance bone fracture healing, a process critically dependent on mesenchymal stem cell differentiation into osteoblasts, is warranted.
Purpose of the Study:
- To investigate the direct effects of 4-aminopyridine (4-AP) on bone fracture healing.
- To assess 4-AP's impact on osteoblast differentiation, proliferation, and matrix formation.
- To evaluate 4-AP's influence on the biomechanical and structural properties of healing bone.
Main Methods:
- Animal experiments were conducted on mice with midshaft tibial fractures, treated with either 4-AP or saline solution.
- Tibiae were analyzed using micro-computed tomography (CT), 3-point bending tests, and histomorphological assessments.
- In vitro studies assessed 4-AP's effects on human bone marrow mesenchymal stem cells (hBMSCs) and human osteoblasts (hOBs) regarding cell viability, migration, proliferation, collagen deposition, and mineralization.
Main Results:
- 4-AP significantly upregulated bone morphogenetic protein 2 (BMP2) and other key bone-forming gene/protein expressions in hBMSCs and hOBs.
- Enhanced osteoblast migration, proliferation, collagen deposition, and matrix mineralization were observed with 4-AP treatment.
- Micro-CT and biomechanical tests showed significant improvements in bone mineral density, bone volume, and stiffness in 4-AP treated mice compared to controls.
Conclusions:
- 4-aminopyridine (4-AP) administration accelerates bone fracture healing rates.
- 4-AP treatment enhances the biomechanical properties and increases endogenous BMP2 expression in healing tibiae.
- These findings suggest 4-AP as a potential therapeutic agent for improving bone fracture repair.
